• Served as project manager for study start-up of three investigator-initiated clinical trials and for dozens of correlative translational research projects.• Co-developed study protocols for three clinical trials evaluating safety and efficacy of novel chemotherapy combinations in triple-negative breast cancer.• Oversaw collection and analysis of clinical data for breast cancer recurrence, treatment response, and biomarker associations.• Reconstructed clinical trial participant database; expanded and streamlined data collection and reporting tools.• Designed experimental approaches for various funding applications.• Helped secure multiple competitive grants from pharmaceutical industry and publicly funded organizations. • Generated chemotherapy-resistant cell lines for high-throughput drug screening.• Launched a student internship program catering to high school and undergraduate students in the Kansas City metropolitan area, with special recruitment emphasis in areas of socioeconomically disadvantaged or historically underrepresented minority students; two program graduates have since been accepted into medical school.• Developed new processes for grant management and financial reporting/analysis.

• Executed and managed contract-based research studies to evaluate the efficacy of biomedical products (e.g. vaccines, therapeutics) under GLP. - Virus propagation, primary cell harvesting, primary cell counting and staining, immunoassays, bacterial load assays.• Managed use of cell culture and immunology laboratory facilities.• Trained staff and students in various cellular/molecular techniques; interviewed applicants.• Developed in vitro and in vivo test systems.• Authored study protocols, standard operating procedures, and technical reports. Supported acquisition of new contracts by drafting proposals and advising on major equipment purchases.• Interfaced between clients, study directors, and quality assurance to ensure the highest possible quality of data delivered in a timely manner.• Developed and executed instrument and assay qualification/validation plans (IQ/OQ/PQ).• Served as instrument calibration specialist for the division. Streamlined calibration and documentation processes to minimize instrument down-time while complying with regulatory requirements.• Scheduled staff and other resources to coordinate multiple concurrent studies.• Spearheaded the implementation of an FDA SEND-ready laboratory information management system (LIMS).

• Expressed tagged and truncated isoforms of NCB5OR, a cytochrome b5-like flavoheme reductase, via CRISPR-Cas9 mutagenesis in a mammalian neuroblastoma line. • Created recombinant protein isoforms for subsequent x-ray crystallography studies• Trained technicians and undergraduate students in various genotyping, PCR, and cell culture techniques.

• Established gas chromatography protocols; developed a customized data analysis method for fatty acid composition as part of ongoing research on docosahexaenoic acid.• Created a laboratory training program for FAME extraction from human blood samples and operation of ChemStation software (including troubleshooting exercises).• Responsible for laboratory operations; developed laboratory methods, SOPs, and optimized protocols.